CVS HEALTH CORPORATION (CVS) Financial Statements
Historical financial data — 41 statements covering FY2016–FY2025
CVS Health offers a diverse set of healthcare services. Its roots are in its retail pharmacy operations, where it operates around 9,000 stores primarily in the US. CVS is also a large pharmacy bene...
CVS HEALTH CORPORATION's revenue increased 7.8% year over year, from $372.81B to $402.07B.
Net income decreased 61.7% over the same period, from $4.61B to $1.77B.
Over the 9-year period from FY2016 to FY2025, revenue grew by 126% in total.
Total debt remained relatively stable at $60.50B.
The debt-to-equity ratio stands at 0.80, indicating a moderate leverage profile.
Operating cash flow grew 16.8% to $10.64B.
CVS HEALTH CORPORATION maintains a moderate net profit margin of 0.4%.
Recent Financial Statements
| Period | Revenue | Net Income | Gross Profit | EBIT | Op. Cash Flow | Total Assets | Total Debt | Equity |
|---|---|---|---|---|---|---|---|---|
| Q3 FY2023 | $263.96B+51.5% | $6.30B | $104.28B | $10.37B | $16.06B | $251.31B | $61.91B | $74.34B |
| Q1 FY2024 | $88.44B-66.5% | $1.11B | $40.36B | $2.27B | $4.90B | $249.74B | $60.41B | $73.97B |
| Q2 FY2024 | $179.67B+103.2% | $2.88B | $81.60B | $5.32B | $7.99B | $252.48B | $62.64B | $74.93B |
| Q3 FY2024 | $275.10B+53.1% | $2.97B | $124.08B | $6.15B | $7.25B | $252.43B | $60.62B | $74.94B |
| Q1 FY2025 | $94.59B-65.6% | $1.78B | $43.53B | $3.37B | $4.56B | $255.59B | $60.30B | $76.93B |
| Q2 FY2025 | $193.50B+104.6% | $2.80B | $88.44B | $5.75B | $6.45B | $258.34B | $60.33B | $77.38B |
| Q3 FY2025 | $296.37B+53.2% | $-1.18B | $134.27B | $2.55B | $7.25B | $255.33B | $61.76B | $72.93B |
| Q1 FY2026 | $100.43B-66.1% | $2.94B | $44.98B | $4.68B | $4.25B | $252.97B | $63.11B | $77.46B |
Balance Sheet Summary (Latest Period)
Total Assets
$253.54B
Total Liabilities
$178.16B
Total Equity
$75.21B
Cash & Equivalents
$10.60B
Total Debt
$60.50B
Current Assets
$74.71B
Current Liabilities
$88.69B
Retained Earnings
$61.20B